Last reviewed · How we verify

NCT05905809: UNIBRACE

Efficacy of UniRelieverTM Offloading Brace in the Management of Knee Osteoarthritis

Completed NA Last updated 17 April 2024
What this trial tests

NA trial testing UniRelieverTM offloading brace (THUASNE) in Osteoarthritis, Knee in 60 participants. Completed in 20 September 2023.

Timeline
7 June 2023
Primary endpoint
20 September 2023
20 September 2023

Quick facts

Lead sponsorThuasne
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment60
Start date7 June 2023
Primary completion20 September 2023
Estimated completion20 September 2023
Sites1 location across Germany

Drugs / interventions tested

Conditions studied

Sponsor

Thuasne

Who can join

18 and older, any sex, with Osteoarthritis, Knee. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to assess the efficacy and performance of a new semi-rigid offloading brace in the management of knee osteoarthritis.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. The effectiveness of the UniReliever offloading knee brace for treating medial knee osteoarthritis: A randomized clinical trial.
    Benning M, Villet S, Marques A, Hilgers RD. · · 2025 · PMID 41331771 · DOI 10.1097/pxr.0000000000000503

Verify or expand the search:

Other recruiting trials for Osteoarthritis, Knee

Currently open trials in the same condition.

Other Thuasne trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05905809.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing